In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway

Pharmaceutical agents for halting the progression of Parkinson’s disease (PD) are lacking. The current available medications only relieve clinical symptoms and may cause severe side effects. Therefore, there is an urgent need for novel drug candidates for PD. In this study, we demonstrated the neuro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mar Drugs
Main Authors: Feng, Chien-Wei, Chen, Nan-Fu, Wen, Zhi-Hong, Yang, Wen-Ya, Kuo, Hsiao-Mei, Sung, Ping-Jyun, Su, Jui-Hsin, Cheng, Shu-Yu, Chen, Wu-Fu
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627894/
https://ncbi.nlm.nih.gov/pubmed/31146323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md17060315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados